Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cordlife

0.245
-0.010-3.92%
Volume:99.60K
Turnover:24.51K
Market Cap:62.80M
PE:-3.32
High:0.250
Open:0.245
Low:0.245
Close:0.255
Loading ...

Company Profile

Company Name:
Cordlife
Exchange:
SGX
Establishment Date:
2001
Employees:
538
Office Location:
1 Kim Seng Promenade,No. 15-01, Great World City East,Singapore,Singapore
Zip Code:
237994
Fax:
65 6238 1108
Introduction:
Cordlife Group Limited is a Singapore-based company that owns cord blood banks in Asia with full stem cell banking facilities in Singapore, Hong Kong, Indonesia, the Philippines, India and Malaysia. The Company’s segments include Banking and Diagnostics. The banking segment comprises the collection, processing and banking of biological materials. The diagnostics segment comprises diagnostics testing services. Its banking services include cord blood, cord lining, cord lining mesenchymal stem cells, corneal lenticule, cord lining epithelial stem cells, cord tissue and others. Its diagnostic testing services include newborn genetic screening, pediatric vision screening, pediatric ear screening, pediatric allergen test, genetic talent test, preimplantation genetic screening, endometrial receptivity test, non-invasive prenatal testing and newborn metabolic screening. Its MOMS UP is a mobile app offering pregnancy, as well as parenting resources for moms and moms-to-be in Asia.